Call for more investment in cost-effective tuberculosis care

[1]  E. McBryde,et al.  Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries , 2020, The Lancet regional health. Western Pacific.

[2]  J. Richardus,et al.  COVID-19 and Tuberculosis-Related Catastrophic Costs , 2020, The American journal of tropical medicine and hygiene.

[3]  S. Bhatt,et al.  Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study , 2020, The Lancet Global Health.

[4]  G. Marks,et al.  Ending Tuberculosis by 2030 -pipe dream or reality? , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[5]  G. Marks,et al.  Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial. , 2019, The Lancet. Global health.

[6]  T. Wingfield,et al.  Active case finding in tuberculosis-affected households: time to scale up. , 2019, The Lancet. Global health.

[7]  G. Fox,et al.  Passive case finding for tuberculosis is not enough , 2016, International journal of mycobacteriology.